Transcat (NASDAQ:TRNS) Director Christopher Gillette Sells 504 Shares

Transcat, Inc. (NASDAQ:TRNSGet Free Report) Director Christopher Gillette sold 504 shares of the company’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $94.23, for a total transaction of $47,491.92. Following the transaction, the director owned 200 shares of the company’s stock, valued at approximately $18,846. The trade was a 71.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Transcat Stock Up 2.5%

TRNS stock opened at $97.76 on Thursday. The stock has a market capitalization of $915.03 million, a PE ratio of 264.22 and a beta of 0.68. The company has a fifty day moving average of $89.90 and a 200-day moving average of $80.38. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.11 and a current ratio of 2.49. Transcat, Inc. has a one year low of $50.23 and a one year high of $98.36.

Transcat (NASDAQ:TRNSGet Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $92.95 million during the quarter, compared to analysts’ expectations of $86.55 million. Transcat had a net margin of 0.99% and a return on equity of 5.56%. As a group, analysts expect that Transcat, Inc. will post 1.74 EPS for the current year.

Institutional Investors Weigh In On Transcat

A number of hedge funds and other institutional investors have recently modified their holdings of TRNS. Teachers Retirement System of The State of Kentucky purchased a new stake in shares of Transcat in the 4th quarter worth about $1,974,000. Needham Investment Management LLC increased its holdings in Transcat by 33.0% during the 4th quarter. Needham Investment Management LLC now owns 124,370 shares of the scientific and technical instruments company’s stock valued at $7,056,000 after acquiring an additional 30,870 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Transcat by 3.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company’s stock valued at $19,244,000 after acquiring an additional 9,266 shares in the last quarter. Fifth Third Bancorp raised its position in Transcat by 6,267.8% during the first quarter. Fifth Third Bancorp now owns 47,886 shares of the scientific and technical instruments company’s stock worth $3,517,000 after acquiring an additional 47,134 shares during the last quarter. Finally, Royce & Associates LP raised its position in Transcat by 15.3% during the fourth quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company’s stock worth $22,156,000 after acquiring an additional 51,774 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on TRNS shares. Wall Street Zen upgraded Transcat from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Weiss Ratings upgraded Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, May 28th. Zacks Research raised Transcat from a “strong sell” rating to a “hold” rating in a report on Friday, May 15th. Finally, Northland Securities lowered shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 target price on the stock. in a research report on Wednesday, August 5th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $105.50.

View Our Latest Research Report on TRNS

About Transcat

(Get Free Report)

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.

Further Reading

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.